Search Results - Jose-Angel Hernandez-Rivas

Refine Results
  1. 1

    Editorial: Elderly patients and lymphoma by Maria S. Infante, José-Angel Hernández-Rivas, José-Angel Hernández-Rivas

    Published in Frontiers in Oncology (2025-03-01)
    Get full text
    Article


  2. 2

    The changing landscape of relapsed and/or refractory multiple myeloma (MM): fundamentals and controversies by José-Ángel Hernández-Rivas, Rafael Ríos-Tamayo, Cristina Encinas, Rafael Alonso, Juan-José Lahuerta

    Published in Biomarker Research (2022-01-01)
    Get full text
    Article


  3. 3

    Iron deficiency anemia: an early clinical presentation of cytomegalovirus-induced hemorrhagic colitis in chronic myeloid leukemia patients under dasatinib treatment by Laura Sanchez-Paz, Pernilla Seidi Tirado Zambrana, Carlos Villa Poza, José-Ángel Hernández-Rivas, Elena Landete Hernández

    Published in Therapeutic Advances in Hematology (2024-10-01)
    Get full text
    Article


  4. 4

    Overall survival outcomes with first‐line continuous ibrutinib and fixed‐duration ibrutinib‐venetoclax treatments in patients with chronic lymphocytic leukemia: Comparison with an... by Paolo Ghia, Loic Ysebaert, Ann Janssens, Stephan Stilgenbauer, Mohamed Fouad, Claudio A. Schioppa, José‐Ángel Hernández‐Rivas, Alessandra Tedeschi

    Published in HemaSphere (2025-10-01)
    Get full text
    Article


  5. 5

    Challenging Diagnosis of Invasive Sinus Aspergillosis Mimicking Gradenigo’s Syndrome in an Elderly Patient with T-Cell Lymphoma by Victoria Ramos de Ascanio, Gloria Liaño-Esteso, David Roldán, Teresa Collazo-Lorduy, Sara Martínez-Flores, José Ángel Hernández-Rivas, Isabel González-Gascón-y-Marín

    Published in Geriatrics (2023-12-01)
    Get full text
    Article


  6. 6

    Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis by Simon Rule, Martin Dreyling, Andre Goy, Georg Hess, Rebecca Auer, Brad Kahl, José-Ángel Hernández-Rivas, Keqin Qi, Sanjay Deshpande, Lori Parisi, Michael Wang

    Published in Haematologica (2019-05-01)
    Get full text
    Article


  7. 7

    Long-term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow-up by Martin Dreyling, Andre Goy, Georg Hess, Brad S. Kahl, José-Ángel Hernández-Rivas, Natasha Schuier, Keqin Qi, Sanjay Deshpande, Angeline Zhu, Lori Parisi, Michael L. Wang

    Published in HemaSphere (2022-05-01)
    Get full text
    Article


  8. 8

    The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment by Claudia Pérez-Carretero, Isabel González-Gascón-y-Marín, Ana E. Rodríguez-Vicente, Miguel Quijada-Álamo, José-Ángel Hernández-Rivas, María Hernández-Sánchez, Jesús María Hernández-Rivas

    Published in Diagnostics (2021-05-01)
    Get full text
    Article


  9. 9

    PB2687: DIGITAL-HEALTH AND REMOTE MONITORING FOR PATIENTS RECEIVING AZACITIDINE AT HOME. A FURTHER STEP TOWARDS HUMANIZATION AND PATIENT-CENTERED MEDICINE by Isabel Gonzalez-Gascon-Y-Marin, María Mir, Alejandro Santiago, Maria Angeles Foncillas Garcia, Teresa Osorio, Francisco-José Ruiz-Gómez, Maria José Solaeta, Victorino Diez, Nuria Suarez-Liceras, Carlos Bibiano-Guillén, Jose Ángel Hernández Rivas

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  10. 10

    PB2293: REAL WORLD STUDY OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN THE ELDERLY: FOURTEEN YEARS OF ONE CENTER’S EXPERIENCE by Victoria Ramos De Ascanio, Alejandro Sanchez Salto, Juan Churruca, Maria Angeles Foncillas Garcia, Isabel González Gascón Y Marín, Elena Landete, Carolina Muñoz Novas, Laura Sanchez Paz, Karen Marin Mori, Jose Ángel Hernández Rivas, Maria Stefania Infante

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  11. 11

    Hypermetabolic abdominal and cervical lymph nodes mimicking Hodgkin lymphoma relapse on FDG PET/CT after adenovirus-vectored COVID-19 vaccine by Elena Landete, Isabel Gómez-Fernández, Isabel González-Gascón-y-Marín, Carmen Durán-Barquero, Juan Churruca, María-Stefania Infante, Carolina Muñoz-Novas, María-Ángeles Foncillas, Karen Marín, Victoria Ramos-de-Ascanio, Juan Carlos Alonso-Farto, José-Ángel Hernández-Rivas

    Published in Human Vaccines & Immunotherapeutics (2021-12-01)
    Get full text
    Article


  12. 12

    Immune response against the SARS-CoV-2 spike protein in cancer patients after COVID-19 vaccination during the Omicron wave: a prospective study by María José Muñoz-Gómez, Pablo Ryan, Marta Quero-Delgado, María Martin-Vicente, Guillermo Cuevas, Jorge Valencia, Eva Jiménez, Natalia Blanca-López, Miguel Ángel Lara-Álvarez, José Ángel Hernández-Rivas, Gerardo Redondo, Vicente Mas, Daniel Sepúlveda-Crespo, Mónica Vázquez, Juan Torres-Macho, Isidoro Martínez, Salvador Resino

    Published in Journal of Infection and Public Health (2024-07-01)
    Get full text
    Article


  13. 13

    Association of Cytogenetics Aberrations and <i>IGHV</i> Mutations with Outcome in Chronic Lymphocytic Leukemia Patients in a Real-World Clinical Setting by Carolina Muñoz-Novas, Isabel González-Gascón-y-Marín, Iñigo Figueroa, Laura Sánchez-Paz, Claudia Pérez-Carretero, Miguel Quijada-Álamo, Ana-Eugenia Rodríguez-Vicente, María-Stefania Infante, María-Ángeles Foncillas, Elena Landete, Juan Churruca, Karen Marín, Victoria Ramos, Alejandro Sánchez Salto, José-Ángel Hernández-Rivas

    Published in Global Medical Genetics (2024-01-01)
    Get full text
    Article


  14. 14

    R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group by Juan‐Manuel Sancho, Rubén Fernández‐Alvarez, Francisco Gual‐Capllonch, Esther González‐García, Carlos Grande, Norma Gutiérrez, María‐Jesús Peñarrubia, Ana Batlle‐López, Eva González‐Barca, José‐María Guinea, Eva Gimeno, Francisco‐Javier Peñalver, Miguel Fuertes, Mariana Bastos, José‐Ángel Hernández‐Rivas, José‐María Moraleda, Olga García, Marc Sorigué, Alejandro Martin

    Published in Cancer Medicine (2021-02-01)
    Get full text
    Article


  15. 15

    Mutational dynamics in patients with del(5q) MDS treated with lenalidomide prior to transfusion dependency—Molecular results from the Sintrarev clinical trial by Sofía Toribio Castelló, Felix López‐Cadenas, Claude Preudhomme, Teresa González, Angela Villaverde Ramiro, Laurène Fenwarth, Blanca Xicoy, Aline Renneville, Joaquín Sánchez‐Garcia, Rosa Coll, Bohrane Slama, José Ángel Hernández‐Rivas, Sylvain Thepot, Teresa Bernal, Agnès Guerci‐Bresler, Raúl Azibeiro, Monica Del Rey, Katharina S. Götze, Pierre Fenaux, Jesús María Hernández‐Rivas, María Díez‐Campelo

    Published in HemaSphere (2026-06-01)
    Get full text
    Article


  16. 16

    Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC)Research... by Pau Abrisqueta, Eva González-Barca, Christelle Ferrà, Eduardo Ríos-Herranz, Margarita Fernández de la Mata, Julio Delgado, Rafael Andreu, José Ángel Hernández-Rivas, María José Terol, Almudena Navarro, M. Belén Vidriales, Patricia Baltasar, Javier De la Serna, Ángel Ramírez, Carmen Ballester, Carol Moreno, José Antonio García-Marco, Raúl Córdoba, Lucrecia Yáñez, Luís Felipe Casado, Marcos González, Francesc Bosch

    Published in EClinicalMedicine (2024-07-01)
    Get full text
    Article


  17. 17

    Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression by Miguel Quijada-Álamo, María Hernández-Sánchez, Ana-Eugenia Rodríguez-Vicente, Claudia Pérez-Carretero, Alberto Rodríguez-Sánchez, Marta Martín-Izquierdo, Verónica Alonso-Pérez, Ignacio García-Tuñón, José María Bastida, María Jesús Vidal-Manceñido, Josefina Galende, Carlos Aguilar, José Antonio Queizán, Isabel González-Gascón y Marín, José-Ángel Hernández-Rivas, Rocío Benito, José Luis Ordóñez, Jesús-María Hernández-Rivas

    Published in Blood Cancer Journal (2021-07-01)
    Get full text
    Article


  18. 18

    Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia by Miguel Quijada‐Álamo, Claudia Pérez‐Carretero, María Hernández‐Sánchez, Ana‐Eugenia Rodríguez‐Vicente, Ana‐Belén Herrero, Jesús‐María Hernández‐Sánchez, Marta Martín‐Izquierdo, Sandra Santos‐Mínguez, Mónica del Rey, Teresa González, Araceli Rubio‐Martínez, Alfonso García de Coca, Julio Dávila‐Valls, José‐Ángel Hernández‐Rivas, Helen Parker, Jonathan C. Strefford, Rocío Benito, José‐Luis Ordóñez, Jesús‐María Hernández‐Rivas

    Published in Clinical and Translational Medicine (2021-02-01)
    Get full text
    Article


  19. 19

    Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study by Isabel Regalado-Artamendi, Ana Jiménez-Ubieto, José Ángel Hernández-Rivas, Belén Navarro, Lucía Núñez, Concha Alaez, Raúl Córdoba, Francisco Javier Peñalver, Jimena Cannata, Pablo Estival, Keina Quiroz-Cervantes, Rosalía Riaza Grau, Alberto Velasco, Rafael Martos, Amalia Domingo-González, Laurentino Benito-Parra, Elvira Gómez-Sanz, Javier López-Jiménez, Arturo Matilla, María Regina Herraez, María José Penalva, Julio García-Suárez, José Luis Díez-Martín, Mariana Bastos-Oreiro

    Published in HemaSphere (2021-03-01)
    Get full text
    Article


  20. 20

    Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients by José Luis Piñana, Inmaculada Heras, Tommaso Francesco Aiello, Irene García-Cadenas, Lourdes Vazquez, Javier Lopez-Jimenez, Pedro Chorão, Cristina Aroca, Carolina García-Vidal, Ignacio Arroyo, Eva Soler-Espejo, Lucia López-Corral, Alejandro Avendaño-Pita, Anna Arrufat, Valentín Garcia-Gutierrez, Elena Arellano, Lorena Hernández-Medina, Clara González-Santillana, Julia Morell, José Ángel Hernández-Rivas, Paula Rodriguez-Galvez, Mireia Mico-Cerdá, Manuel Guerreiro, Diana Campos, David Navarro, Ángel Cedillo, Rodrigo Martino, Carlos Solano

    Published in Viruses (2023-10-01)
    Get full text
    Article


Search Tools: